Study Evaluating Prevenar Vaccine in Healthy Infants

Inclusion Criteria:

• Healthy male and female children 2 months of age (42 to 100 days) in good health.
• An informed consent must be signed by a parent or legal guardian following a detailed explanation of participation in the study.
• Infants whose parent(s)/guardian(s) will be available for the entire study period.

Exclusion Criteria:

• Hypersensitivity to any component of the vaccine, including diphtheria toxoid
• Infants with thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injection
• Infants with known or suspected impairment of immunologic functions including HIV or those receiving immunosuppressive therapy.

Other exclusions apply.